Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 475

1.

Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.

Voors AA, Shah SJ, Bax JJ, Butler J, Gheorghiade M, Hernandez AF, Kitzman DW, McMurray JJV, Wirtz AB, Lanius V, van der Laan M, Solomon SD.

Eur J Heart Fail. 2018 Sep 17. doi: 10.1002/ejhf.1295. [Epub ahead of print]

PMID:
30225882
2.

Very early diuretic response after admission for acute heart failure.

Kuroda S, Damman K, Ter Maaten JM, Voors AA, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kitai T, Yoshida K, Matsumura A, Matsue Y.

J Card Fail. 2018 Sep 13. pii: S1071-9164(18)30984-9. doi: 10.1016/j.cardfail.2018.09.004. [Epub ahead of print]

PMID:
30219549
3.

Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).

Fudim M, Parikh KS, Dunning A, DeVore AD, Mentz RJ, Schulte PJ, Armstrong PW, Ezekowitz JA, Tang WHW, McMurray JJV, Voors AA, Drazner MH, O'Connor CM, Hernandez AF, Patel CB.

Am J Cardiol. 2018 Aug 3. pii: S0002-9149(18)31495-4. doi: 10.1016/j.amjcard.2018.07.023. [Epub ahead of print]

PMID:
30172362
4.

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.

Tromp J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Lang CC, Ng LL, Zannad F, Zwinderman AH, Hillege HL, van der Meer P, Voors AA.

J Am Coll Cardiol. 2018 Sep 4;72(10):1081-1090. doi: 10.1016/j.jacc.2018.06.050.

PMID:
30165978
5.

Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction.

Santema BT, Kloosterman M, Van Gelder IC, Mordi I, Lang CC, Lam CSP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Van der Harst P, Hillege HL, Ter Maaten JM, Metra M, Ng LL, Ponikowski P, Samani NJ, Van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, Van der Meer P, Rienstra M, Voors AA.

Eur Heart J. 2018 Aug 22. doi: 10.1093/eurheartj/ehy421. [Epub ahead of print]

PMID:
30137304
6.

Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production.

Du W, Piek A, Schouten EM, van de Kolk CWA, Mueller C, Mebazaa A, Voors AA, de Boer RA, Silljé HHW.

Theranostics. 2018 Jul 30;8(15):4155-4169. doi: 10.7150/thno.26055. eCollection 2018.

7.

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure.

Linssen GCM, Jaarsma T, Hillege HL, Voors AA, van Veldhuisen DJ.

Neth Heart J. 2018 Oct;26(10):486-492. doi: 10.1007/s12471-018-1145-x.

PMID:
30088253
8.

OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction.

van der Pol A, Gil A, Tromp J, Silljé HHW, van Veldhuisen DJ, Voors AA, Hoendermis ES, Grote Beverborg N, Schouten EM, de Boer RA, Bischoff R, van der Meer P.

Cardiovasc Res. 2018 Jul 19. doi: 10.1093/cvr/cvy187. [Epub ahead of print]

PMID:
30032247
9.

Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial.

Grodin JL, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Hernandez AF, O'Connor C, Starling RC, Tang WHW.

J Card Fail. 2018 Aug;24(8):512-519. doi: 10.1016/j.cardfail.2018.06.008.

PMID:
30012361
10.

Waist-to-hip ratio and mortality in heart failure.

Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Lang CC.

Eur J Heart Fail. 2018 Jul 2. doi: 10.1002/ejhf.1244. [Epub ahead of print]

PMID:
29963737
11.

Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure.

Kremer D, Ter Maaten JM, Voors AA.

Eur J Heart Fail. 2018 Sep;20(9):1363-1365. doi: 10.1002/ejhf.1245. Epub 2018 Jun 22. No abstract available.

PMID:
29932477
12.

Heart failure with preserved ejection fraction: from mechanisms to therapies.

Lam CSP, Voors AA, de Boer RA, Solomon SD, van Veldhuisen DJ.

Eur Heart J. 2018 Aug 7;39(30):2780-2792. doi: 10.1093/eurheartj/ehy301.

PMID:
29905796
14.

Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.

Suthahar N, Meijers WC, Ho JE, Gansevoort RT, Voors AA, van der Meer P, Bakker SJL, Heymans S, van Empel V, Schroen B, van der Harst P, van Veldhuisen DJ, de Boer RA.

Eur J Heart Fail. 2018 Aug;20(8):1205-1214. doi: 10.1002/ejhf.1209. Epub 2018 Jun 1.

PMID:
29855124
15.

Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data.

Metra M, Cotter G, Senger S, Edwards C, Cleland JG, Ponikowski P, Cursack GC, Milo O, Teerlink JR, Givertz MM, O'Connor CM, Dittrich HC, Bloomfield DM, Voors AA, Davison BA.

Circ Heart Fail. 2018 May;11(5):e004644. doi: 10.1161/CIRCHEARTFAILURE.117.004644.

PMID:
29748350
16.

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.

Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Pérez-Calvo JI, Voors AA.

Int J Cardiol. 2018 May 1;258:185-191. doi: 10.1016/j.ijcard.2018.01.067.

PMID:
29544928
17.

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.

Cerbin LP, Ambrosy AP, Greene SJ, Armstrong PW, Butler J, Coles A, DeVore AD, Ezekowitz JA, Hernandez AF, Metra M, Starling RC, Tang W, Teerlink JR, Voors AA, Wu A, O'Connor CM, Mentz RJ.

JACC Heart Fail. 2018 Apr;6(4):298-307. doi: 10.1016/j.jchf.2018.01.018. Epub 2018 Mar 7.

PMID:
29525328
18.

Risk stratification in acute heart failure: reply.

Demissei BG, Voors AA.

Eur J Heart Fail. 2018 May;20(5):945-947. doi: 10.1002/ejhf.1171. Epub 2018 Mar 7. No abstract available.

PMID:
29512236
19.

Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL? Reply.

Ng LL, Voors AA.

Eur J Heart Fail. 2018 Jun;20(6):1077-1078. doi: 10.1002/ejhf.1173. Epub 2018 Mar 2. No abstract available.

PMID:
29498159
20.

Sense and Sensibility of the Use of NT-proBNP for Eligibility in Clinical Trials.

Voors AA.

JACC Heart Fail. 2018 Mar;6(3):257-259. doi: 10.1016/j.jchf.2018.01.003. Epub 2018 Feb 7. No abstract available.

PMID:
29428436
21.

Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.

Ouwerkerk W, Zwinderman AH, Ng LL, Demissei B, Hillege HL, Zannad F, van Veldhuisen DJ, Samani NJ, Ponikowski P, Metra M, Ter Maaten JM, Lang CC, van der Harst P, Filippatos G, Dickstein K, Cleland JG, Anker SD, Voors AA.

J Am Coll Cardiol. 2018 Jan 30;71(4):386-398. doi: 10.1016/j.jacc.2017.11.041.

PMID:
29389354
22.

Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.

Grote Beverborg N, Klip IT, Meijers WC, Voors AA, Vegter EL, van der Wal HH, Swinkels DW, van Pelt J, Mulder AB, Bulstra SK, Vellenga E, Mariani MA, de Boer RA, van Veldhuisen DJ, van der Meer P.

Circ Heart Fail. 2018 Feb;11(2):e004519. doi: 10.1161/CIRCHEARTFAILURE.117.004519.

PMID:
29382661
23.

N-terminal pro-B-type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure.

Tromp J, Richards AM, Tay WT, Teng TK, Yeo PSD, Sim D, Jaufeerally F, Leong G, Ong HY, Ling LH, van Veldhuisen DJ, Jaarsma T, Voors AA, van der Meer P, de Boer RA, Lam CSP.

ESC Heart Fail. 2018 Apr;5(2):279-287. doi: 10.1002/ehf2.12252. Epub 2018 Jan 30.

24.

Heart failure with mid-range ejection fraction: causes and consequences.

Tromp J, Voors AA, Lam CSP.

Eur J Heart Fail. 2018 Apr;20(4):660-662. doi: 10.1002/ejhf.1134. Epub 2018 Jan 16. No abstract available.

PMID:
29336093
25.

Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.

Beusekamp JC, Tromp J, van der Wal HH, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Rossignol P, Zannad F, Voors AA, van der Meer P.

Eur J Heart Fail. 2018 May;20(5):923-930. doi: 10.1002/ejhf.1079. Epub 2018 Jan 12.

PMID:
29327797
26.

Diabetes Mellitus and Right Ventricular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Gorter TM, Streng KW, van Melle JP, Rienstra M, Dickinson MG, Lam CSP, Hummel YM, Voors AA, Hoendermis ES, van Veldhuisen DJ.

Am J Cardiol. 2018 Mar 1;121(5):621-627. doi: 10.1016/j.amjcard.2017.11.040. Epub 2017 Dec 11.

PMID:
29307460
27.

Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.

Metra M, Davison BA, Gimpelewicz C, Carubelli V, Felker GM, Filippatos G, Greenberg BH, Hua TA, Liu Z, Pang PS, Ponikowski P, Severin TM, Voors AA, Wang Y, Cotter G, Teerlink JR.

Int J Cardiol. 2018 Feb 15;253:91-96. doi: 10.1016/j.ijcard.2017.09.185.

PMID:
29306479
28.

Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.

Ter Maaten JM, Voors AA, Damman K, van der Meer P, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Navis G, Ng L, Ouwerkerk W, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, de Borst MH.

Int J Cardiol. 2018 Feb 15;253:84-90. doi: 10.1016/j.ijcard.2017.10.010.

29.

Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.

Pokorney SD, Al-Khatib SM, Sun JL, Schulte P, O'Connor CM, Teerlink JR, Armstrong PW, Ezekowitz JA, Starling RC, Voors AA, Velazquez EJ, Hernandez AF, Mentz RJ.

Eur J Heart Fail. 2018 Mar;20(3):525-532. doi: 10.1002/ejhf.1078. Epub 2017 Dec 20.

PMID:
29266564
30.

Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients.

Petrie CJ, Ponikowski P, Metra M, Mitrovic V, Ruda M, Fernandez A, Vishnevsky A, Cotter G, Milo O, Laessing U, Zhang Y, Dahlke M, Zymlinski R, Voors AA.

Clin Exp Hypertens. 2018;40(7):637-643. doi: 10.1080/10641963.2017.1416121. Epub 2017 Dec 21.

PMID:
29265934
31.

Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure.

Emmens JE, Jones DJL, Cao TH, Chan DCS, Romaine SPR, Quinn PA, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, de Boer RA, Voors AA, Ng LL.

Eur J Heart Fail. 2018 Feb;20(2):260-267. doi: 10.1002/ejhf.1101. Epub 2017 Dec 18.

PMID:
29251807
32.

Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation.

Gorter TM, van Melle JP, Rienstra M, Borlaug BA, Hummel YM, van Gelder IC, Hoendermis ES, Voors AA, van Veldhuisen DJ, Lam CSP.

J Card Fail. 2018 Mar;24(3):177-185. doi: 10.1016/j.cardfail.2017.11.005. Epub 2017 Nov 29.

33.

Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH.

van der Pol A, Gil A, Silljé HHW, Tromp J, Ovchinnikova ES, Vreeswijk-Baudoin I, Hoes M, Domian IJ, van de Sluis B, van Deursen JM, Voors AA, van Veldhuisen DJ, van Gilst WH, Berezikov E, van der Harst P, de Boer RA, Bischoff R, van der Meer P.

Sci Transl Med. 2017 Nov 8;9(415). pii: eaam8574. doi: 10.1126/scitranslmed.aam8574.

PMID:
29118264
34.

Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with 13N-NH3 positron emission tomography and echocardiography.

Assa S, Kuipers J, Ettema E, Gaillard CAJM, Krijnen WP, Hummel YM, Voors AA, van Melle JP, Westerhuis R, Willemsen A, Slart RHJA, Franssen CFM.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F445-F452. doi: 10.1152/ajprenal.00368.2017. Epub 2017 Nov 8.

PMID:
29117996
35.

Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.

Fudim M, O'Connor CM, Dunning A, Ambrosy AP, Armstrong PW, Coles A, Ezekowitz JA, Greene SJ, Metra M, Starling RC, Voors AA, Hernandez AF, Michael Felker G, Mentz RJ.

Eur J Heart Fail. 2018 Feb;20(2):304-314. doi: 10.1002/ejhf.1020. Epub 2017 Oct 29.

PMID:
29082629
36.

What have we learned about heart failure with mid-range ejection fraction one year after its introduction?

Nauta JF, Hummel YM, van Melle JP, van der Meer P, Lam CSP, Ponikowski P, Voors AA.

Eur J Heart Fail. 2017 Dec;19(12):1569-1573. doi: 10.1002/ejhf.1058. Epub 2017 Oct 24. Review.

PMID:
29067761
37.

The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.

Bayes-Genis A, Núñez J, Zannad F, Ferreira JP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Metra M, Lupón J, Voors AA.

J Am Coll Cardiol. 2017 Oct 24;70(17):2128-2136. doi: 10.1016/j.jacc.2017.08.057.

38.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.

Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA, Lam CSP, Ponikowski P, Temple T, Pieske B, Ezekowitz J, Hernandez AF, Koglin J, O'Connor CM.

JACC Heart Fail. 2018 Feb;6(2):96-104. doi: 10.1016/j.jchf.2017.08.013. Epub 2017 Oct 11. Review.

39.

Prevalence and predictive value of electrocardiographic abnormalities in pulmonary hypertension: evidence from the Pan-African Pulmonary Hypertension Cohort (PAPUCO) study.

Balieva I, Dzudie A, Thienemann F, Mocumbi AO, Karaye K, Sani MU, Ogah OS, Voors AA, Kengne AP, Sliwa K.

Cardiovasc J Afr. 2017 Nov/Dec 23;28(6):370-376. doi: 10.5830/CVJA-2017-020. Epub 2017 Oct 11.

40.

Lessons Learned and to Be Learned About the Use of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure and Atrial Fibrillation.

Voors AA, Lam CSP.

Circ Heart Fail. 2017 Oct;10(10). pii: e004552. doi: 10.1161/CIRCHEARTFAILURE.117.004552. No abstract available.

PMID:
29018175
41.

Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Cotter G, Davison BA, Butler J, Collins SP, Ezekowitz JA, Felker GM, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Senger S, Bharucha D, Goin K, Soergel DG, Pang PS.

Clin Res Cardiol. 2018 Feb;107(2):170-181. doi: 10.1007/s00392-017-1168-0. Epub 2017 Oct 6.

PMID:
28986703
42.

Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.

Hummel YM, Liu LCY, Lam CSP, Fonseca-Munoz DF, Damman K, Rienstra M, van der Meer P, Rosenkranz S, van Veldhuisen DJ, Voors AA, Hoendermis ES.

Eur J Heart Fail. 2017 Dec;19(12):1651-1660. doi: 10.1002/ejhf.957. Epub 2017 Oct 6.

PMID:
28984057
43.

Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.

van Boven N, Kardys I, van Vark LC, Akkerhuis KM, de Ronde MWJ, Khan MAF, Merkus D, Liu Z, Voors AA, Asselbergs FW, van den Bos EJ, Boersma E, Hillege H, Duncker DJ, Pinto YM, Postmus D.

Eur J Heart Fail. 2018 Jan;20(1):89-96. doi: 10.1002/ejhf.950. Epub 2017 Sep 25.

PMID:
28948688
44.

Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure.

Dickinson MG, Lam CS, Rienstra M, Vonck TE, Hummel YM, Voors AA, Hoendermis ES.

Eur J Heart Fail. 2017 Nov;19(11):1483-1490. doi: 10.1002/ejhf.959. Epub 2017 Sep 25.

PMID:
28948687
45.

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.

Gimpelewicz C, Metra M, Cleland JGF, Szecsödy P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR.

Am Heart J. 2017 Aug;190:113-122. doi: 10.1016/j.ahj.2017.05.012. Epub 2017 May 27.

46.

Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR.

Clin Res Cardiol. 2017 Nov;106(11):938. doi: 10.1007/s00392-017-1139-5. No abstract available.

PMID:
28752374
47.

Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO2 Slope in Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension.

Klaassen SHC, Liu LCY, Hummel YM, Damman K, van der Meer P, Voors AA, Hoendermis ES, van Veldhuisen DJ.

J Card Fail. 2017 Nov;23(11):777-782. doi: 10.1016/j.cardfail.2017.07.397. Epub 2017 Jul 20.

48.

Atrial Fibrillation in Heart Failure: A Common and Deadly Combination.

Lam CSP, Santema BT, Voors AA.

JACC Heart Fail. 2017 Aug;5(8):575-577. doi: 10.1016/j.jchf.2017.05.010. Epub 2017 Jul 12. No abstract available.

49.

The Fastest Way to the Failing Heart Is Through the Kidneys.

Damman K, Voors AA.

JACC Heart Fail. 2017 Sep;5(9):682-683. doi: 10.1016/j.jchf.2017.06.001. Epub 2017 Jul 12. No abstract available.

50.

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency.

van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, Böhm M, Doletsky A, Voors AA, Macdougall IC, Anker SD, Roubert B, Zakin L, Cohen-Solal A; EFFECT-HF Investigators.

Circulation. 2017 Oct 10;136(15):1374-1383. doi: 10.1161/CIRCULATIONAHA.117.027497. Epub 2017 Jul 12.

Supplemental Content

Loading ...
Support Center